Litcius/Paper detail

Efficacy and safety of immune checkpoint inhibitors for individuals with advanced EGFR-mutated non-small-cell lung cancer who progressed on EGFR tyrosine-kinase inhibitors: a systematic review, meta-analysis, and network meta-analysis

Yi Zhao, Ying He, Wei Wang, Qi Cai, Fan Ge, Zisheng Chen, Jianqi Zheng, Yuan Zhang, Hongsheng Deng, Ying Chen, Shen Lao, Hengrui Liang, Wenhua Liang, Jianxing He

2024The Lancet Oncology60 citationsDOI

Topics & Concepts

Lung cancerMedicineMeta-analysisTyrosine kinaseCancer researchOncologyInternal medicineReceptorCancer Immunotherapy and BiomarkersLung Cancer Treatments and MutationsLung Cancer Research Studies